MTWM
OPK icon

Masso Torrence Wealth Management’s Opko Health OPK Stock Holding History

Masso Torrence Wealth Management’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-839
Closed -$4K – 266
2021
Q4 		$4K Buy
+839
New +$3.4K ﹤0.01% 323

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Masso Torrence Wealth Management's OPK Position: Q1 2022 in Review

Masso Torrence Wealth Management sold out of Opko Health (OPK) in Q1 2022, closing a stake of 839 shares — an estimated $4K sold.

Masso Torrence Wealth Management first reported a position in OPK in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 229 funds tracked by Wall St. Rank hold OPK as of Q1 2022.

  • Masso Torrence Wealth Management reported no remaining Opko Health position as of Q1 2022 after selling out during the quarter.
  • Masso Torrence Wealth Management sold 839 Opko Health shares in Q1 2022, an estimated $4K.
  • Masso Torrence Wealth Management first reported a position in Opko Health in Q4 2021 and held it in 1 quarter.
  • Masso Torrence Wealth Management's Opko Health position peaked at $4K in Q4 2021.
  • 229 funds tracked by Wall St. Rank held Opko Health as of Q1 2022.

Based on Masso Torrence Wealth Management's 13F filing for Q1 2022, filed 26 Apr 2022.